Logo

Cepheid's Shares Rise on New GeneXpert Release

Jan 07, 2008
NEW YORK (GenomeWeb News) - Cepheid’s share price rose 5.4 percent, or $1.38, to $27.10 in mid-afternoon trading following the company’s announcement this morning that it is now shipping new versions of its GeneXpert system.
 
The company said the new system offers increased color capability, detection of up to 60 targets in one cartridge, and software for integrating laboratory information systems.

Breaking News
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.